ClinicalTrials.Veeva

Menu

Gastric Cancer Liver Metastasis Cohort of China (RECORD)

C

Chinese PLA General Hospital (301 Hospital)

Status

Active, not recruiting

Conditions

Neoplasm Metastasis
Stomach Neoplasms

Treatments

Procedure: Gastrectomy; Hepatectomy

Study type

Observational

Funder types

Other

Identifiers

NCT04574245
S2020-381

Details and patient eligibility

About

This multi-institutional retrospective cohort study aimed to describe and analyze the overall clinical characteristics, therapeutic status and prognosis pattern of gastric cancer liver metastasis (GCLM) in China.

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gastric cancer liver metastases cases aged over 18 years old;
  • Primary gastric carcinoma (including different histopathological types) confirmed by biopsy or surgery (pre-, intra- or post- treatment);
  • In hospital cases between 2020/01/01 to 2019/12/3.

Exclusion criteria

  • Poor compliance to treatment or lost to follow-up;
  • Gross loss of clinical data.

Trial design

3,000 participants in 3 patient groups

Resectable group
Treatment:
Procedure: Gastrectomy; Hepatectomy
Potentially resectable group
Unresectable group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems